On the other hand, a recent Malaysian study reported that SLCO1B1 T89595C (rs4363657) polymorphism was a significant risk factor for statin-induced myopathy in heterozygote carriers compared to wild-type and variant homozygotes. The gene discussed is SLCO1B1; the disease is myopathy.